2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1,3,4-oxadiazole
Structure Info
- Chemspace ID
- CSSB00010270274 (In-Stock Building Blocks)
- CAS
- 2096339-94-3
- MFCD
- MFCD20486751, MFCD20486751
- IUPAC Name
- 2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1,3,4-oxadiazole
- Mol formula
- C15H19BN2O3
- Mol weight
- 286 Da
- Catalog Number(s)
- A614616, AG01EKXW, AR01ELMW, AX59740, BB4LS-EN300-6489259, BBLS00010270274, BBV-77964469, BD01337647, CS-0256456, CSC010270274, EN300-6489259, HY-W193737, TX01EM3K, WID33994, Y3240178, Z3234965033, bbls00010270274
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.59
- Heavy atoms count
- 21
- Rotatable bond count
- 3
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.466
- Polar surface area (Å)
- 57
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
![Chemical structure of 2-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1,3,4-oxadiazole (C15H19BN2O3) - CSSB00010270274](/st/structure/200/1d64e82ef40c38626e1d5270beea9c8d/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528CC2%253DNN%253DCO2%2529C%253DC1.png "C15H19BN2O3")
- Zoom the structure
- CSSB00010270274
Items Overall 29 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BB4LS US | 2 days | United States To: | 95 | 50 umol | 175.48 | |
| BB4LS US | 2 days | United States To: | 95 | 100 umol | 248.04 | |
| BB4LS US | 2 days | United States To: | 95 | 200 umol | 339.00 | |
| BB4LS US | 2 days | United States To: | 95 | 300 umol | 433.00 | |
| BB4LS US | 2 days | United States To: | 95 | 500 umol | 535.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 309.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 461.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 658.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 1,037.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 1,328.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 2,605.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 3,852.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 50 mg | 309.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 100 mg | 461.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 250 mg | 658.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 500 mg | 1,037.00 | |
| Enamine LV SIA | 5 days | Latvia To: | 95 | 1 g | 1,328.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 309.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 461.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 658.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 1,037.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 1,328.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 2,605.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 5 g | 3,852.00 | |
| BB4LS EU | 7 days | Latvia To: | 95 | 50 umol | 175.48 | |
| BB4LS EU | 7 days | Latvia To: | 95 | 100 umol | 248.04 | |
| BB4LS EU | 7 days | Latvia To: | 95 | 200 umol | 339.00 | |
| BB4LS EU | 7 days | Latvia To: | 95 | 300 umol | 433.00 | |
| BB4LS EU | 7 days | Latvia To: | 95 | 500 umol | 535.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 2-methyl-5-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1,3,4-oxadiazole - CSSB00010270276](/st/structure/200/419d6772da85c274470b373c7a72c460/CC1%253DNN%253DC%2528CC2%253DCC%253DC%2528C%253DC2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529O1.png)
Similarity Analogs
![Chemical structure of 2-{[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1,3,4-oxadiazole - CSSB00010270275](/st/structure/200/9e3aefea9cea93639a9b5bdb9884ce68/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528CC2%253DNN%253DCO2%2529%253DC1.png)
![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010246424](/st/structure/200/e935dfe232b4d585fec5d032ab406155/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010144809](/st/structure/200/493e98023a91f6d044789a829f1f6afd/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C1%253DNN%253DCO1.png)
![Chemical structure of 4,4,5,5-tetramethyl-2-{4-[(thiophen-2-yl)methyl]phenyl}-1,3,2-dioxaborolane - CSSB00010244141](/st/structure/200/7ae4fc9ef0617eba14f46de9eeefba1b/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528CC2%253DCC%253DCS2%2529C%253DC1.png)
![Chemical structure of 1-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}piperidine - CSSB00000767125](/st/structure/200/db2fa6f3fb8cf665e01eefd67d322c6a/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528CN2CCCCC2%2529C%253DC1.png)
![Chemical structure of 1-{[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}azepane - CSSB00011830233](/st/structure/200/913a35505ea3cdc049103082b4d2ea72/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528CN2CCCCCC2%2529C%253DC1.png)
